CIN News

Rare genetic variants confer largest increase in type 2 diabetes risk seen to date

7 July 2021

Scientists at the University of Cambridge have identified rare genetic variants – carried by one in 3,000 people – that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect. Read the original article here>

Scientists identify 160 new drugs that could be repurposed against COVID-19

30 June 2021

Cambridge scientists have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials. Read the original article here>

Upgrading PPE for staff working on COVID-19 wards cut hospital-acquired infections dramatically

29 June 2021

When Addenbrooke’s Hospital in Cambridge upgraded its face masks for staff working on COVID-19 wards to filtering face piece 3 (FFP3) respirators, it saw a dramatic fall – up to 100% – in hospital-acquired SARS-CoV-2 infections among these staff. Read the original article here>

Targeting cellular response to SARS-CoV-2 holds promise as new way to fight infection

17 June 2021

A new treatment approach focused on fixing cell damage, rather than fighting the virus directly, is effective against SARS-CoV-2 in lab models. If found safe for human use, this anti-viral treatment would make COVID-19 symptoms milder and speed up recovery times. Read the original article here>

How mass testing helped limit the spread of COVID-19 at the University of Cambridge.

1 June 2021

A combination of testing programmes for staff and students, infection control measures and genomic surveillance helped reduce the number of cases of COVID-19 at the University of Cambridge and keep the wider community safe. Read the original article here>

Cambridge researchers awarded the Millennium Technology Prize

18 May 2021

British duo Professor Shankar Balasubramanian and Professor David Klenerman have been awarded the Millennium Technology Prize for their development of revolutionary DNA sequencing techniques. Read the original article here>

The Academy of Medical Sciences announces election of new Fellows 2021

12 May 2021

Cambridge scientists are among the new Fellows announced today by the Academy of Medical Sciences. The Academy of Medical Sciences has elected 50 prominent biomedical and health scientists to its respected and influential Fellowship. The new Fellows have been selected for their exceptional contributions to the advancement...

Ability of multi-drug resistant infection to evolve within cystic fibrosis patients highlights need for rapid treatment

29 April 2021

Scientists have been able to track how a multi-drug resistant organism is able to evolve and spread widely among cystic fibrosis patients – showing that it can evolve rapidly within an individual during chronic infection. Read the original article here>

New cancer algorithm flags genetic weaknesses in tumours

27 April 2021

A new way to identify tumours that could be sensitive to particular immunotherapies has been developed using data from thousands of NHS cancer patient samples sequenced through the 100,000 Genomes Project. Read the original article here>

Scientists develop new class of cancer drug with potential to treat leukaemia

26 April 2021

Scientists have made a promising step towards developing a new drug for treating acute myeloid leukaemia, a rare blood disorder. In a study published today in Nature, Cambridge researchers report a new approach to cancer treatment that targets enzymes which play a key role in translating DNA into proteins and which could...

Rare genetic variants confer largest increase in type 2 diabetes risk seen to date

Scientists identify 160 new drugs that could be repurposed against COVID-19

Upgrading PPE for staff working on COVID-19 wards cut hospital-acquired infections dramatically

Targeting cellular response to SARS-CoV-2 holds promise as new way to fight infection

How mass testing helped limit the spread of COVID-19 at the University of Cambridge.

Cambridge researchers awarded the Millennium Technology Prize

The Academy of Medical Sciences announces election of new Fellows 2021

Ability of multi-drug resistant infection to evolve within cystic fibrosis patients highlights need for rapid treatment

New cancer algorithm flags genetic weaknesses in tumours

Scientists develop new class of cancer drug with potential to treat leukaemia

Contact us

Contact: webmaster@immunology.cam.ac.uk

Site Privacy & Cookie Policies

twitter_icon.png

youtube-icon.png

newsletter_icon.png

We are a FOCIS centre of Excellence

focis_logo_no-web.png

Read more

Study at Cambridge

About the University

Research at Cambridge